Myriam Seemann graduated from the Ecole Nationale Supérieure de Chimie de Mulhouse in 1992 where she obtained her Ph.D in 1995 and worked on the elucidation of the early stage of a new pathway for the biosynthesis of isopentenyl diphosphate in the group of Prof. Michel Rohmer. She pursued her career as a postdoctoral fellow in the group of Prof. Wolf Woggon at the University of Basel (Switzerland) and moved to Brown University (USA) in 1997 as a research associate in the group of Prof. David Cane.
She was recruited by the Centre National de la Recherche Scientifique (CNRS) in 1999 and joined the Strasbourg Institute of Chemistry, a University of Strasbourg/CNRS joint research Institute, where she got promoted to research director in 2012. Since 2014 she is leading the biological chemistry and therapeutic applications (CBAT) team. Her current research at the interface between chemistry and biology focuses on the inhibition of enzymes that are targets for the design of new antibacterials with a main interest in the MEP pathway. Her team is also engaged in the development of cutting-edge research to produce and characterize oxygen sensitive metalloenzymes.
She was a recipient of the ‘Bronze Medal’ of the CNRS and awarded several researcher funds from the French National Research Agency. She is member of the FrenchBIC board (CNRS network for Bioinorganic chemistry).